HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

DocTalk

Get your health care new fix here on DocTalk, the flagship series from HCPLive delivering updates and interviews on breaking news in medicine every week.

FDA Approves Ruxolitinib: New Horizons in Vitiligo Care

July 21, 2022

Dr. David Rosmarin details the recent FDA approval of ruxolitinib cream for vitiligo and how the accessibility of the topical therapy could help the roughly one million patients in the US who can't access standard treatment.

What Ustekinumab Provides in Long-Term IBD Care

June 30, 2022

Dr. Remo Panaccione speaks on promising long-term data of ustekinumab for Crohn's disease and ulcerative colitis, and how it could function as either a first-line treatment or alternative option for patients who were previously exposed biologic therapies.

Dermatologists Discuss the FDA Approval of Baricitinib for Alopecia Areata

June 16, 2022

Several prominent dermatologists sound off on the implications of this decision, JAK inhibitors, and how this approval will aid providers in redefining alopecia areata as an autoimmune disorder rather than simply a cosmetic condition.